Becton, Dickinson and Company (BDX)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 11:25AM EST. Market open.
| Previous Close | 251.82 |
| Open | 251.57 |
| Bid | 251.69 x 900 |
| Ask | 251.81 x 800 |
| Day's Range | 250.69 - 252.97 |
| 52 Week Range | 215.90 - 277.29 |
| Volume | |
| Avg. Volume | 1,432,488 |
| Market Cap | 71.607B |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | 47.80 |
| EPS (TTM) | 5.26 |
| Earnings Date | Feb 01, 2023 - Feb 06, 2023 |
| Forward Dividend & Yield | 3.48 (1.51%) |
| Ex-Dividend Date | Sept 08, 2022 |
| 1y Target Est | 277.82 |
- Zacks
Cardinal Health (CAH) to Post Q2 Earnings: What's in Store?
Cardinal Health's (CAH) second-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have continued.
- Zacks
McKesson (MCK) to Report Q3 Earnings: Is a Beat in the Cards?
McKesson's (MCK) fiscal third-quarter results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment.
- Zacks
Becton Dickinson (BDX) Expected to Beat Earnings Estimates: Should You Buy?
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2023 Yahoo. All rights reserved.
